Newsroom

International Collaborations – Salud con Datos 2019

International collaborations accelerate patient advocacy and affect policy changes and treatment protocols On May 7th, representatives from Colombia, Chile, Mexico, and The Life Raft Group assembled for the annual Salud con Datos [...]

By |2019-07-03T15:15:33-04:00June 20th, 2019|Global, News, Newsletter|

Update on a New Clinical Trial Offered to Eligible GIST Patients

The INTRIGUE study is a Phase 3 clinical trial testing the investigational drug ripretinib (DCC-2618) for patients living with GIST that are no longer on imatinib due to progression or intolerance.

By |2019-08-21T11:40:48-04:00June 20th, 2019|Clinical Trials, News, Newsletter|

LRG Webcast: Symptom and Side Effect Management

Symptom and Side Effect Management of GIST Treatment GIST and its treatment can cause a variety of symptoms. Adequate management of symptoms can improve a patient’s quality of life. Proper management can also allow [...]

By |2020-07-09T17:07:58-04:00June 20th, 2019|GIST Education, Side Effects, Webcast|

One Voice Against Cancer (OVAC) Advocates for Cancer Patients

OVAC is a coalition of over 50 nonprofit cancer organizations that advocate on behalf of cancer patients to deliver a unified message to Congress and to the White House on the need for increased [...]

By |2019-07-02T14:28:52-04:00June 20th, 2019|Advocacy, News, Newsletter|

The LRG GIST Peer Support Program

[Please note that GIST Peer Support program has been renamed the GIST Mentor Program 11.5.19]. Last month, we posted information on our new program to support our members. The GIST Peer Program is an additional support system to help patients and their caregivers through a very difficult time in their lives. Why? They may just be finding out they or a loved one has GIST, or they are experiencing a recurrence and they want to be able to talk with someone.

By |2019-11-05T17:10:28-05:00June 20th, 2019|News, Newsletter, Patient Support|
Go to Top